DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 3 filers reported holding DIPLOMAT PHARMACY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | -41.7% | 1,829 | -26.8% | 0.00% | -33.3% |
| Q3 2019 | $12,000 | +50.0% | 2,497 | +86.8% | 0.01% | +50.0% |
| Q2 2019 | $8,000 | +300.0% | 1,337 | +585.6% | 0.00% | – |
| Q1 2019 | $2,000 | -90.0% | 195 | -87.4% | 0.00% | -100.0% |
| Q4 2018 | $20,000 | -31.0% | 1,542 | +1.0% | 0.01% | -25.0% |
| Q3 2018 | $29,000 | -32.6% | 1,527 | -10.3% | 0.01% | -33.3% |
| Q2 2018 | $43,000 | +26.5% | 1,703 | +0.7% | 0.02% | +28.6% |
| Q1 2018 | $34,000 | 0.0% | 1,692 | -2.0% | 0.01% | 0.0% |
| Q4 2017 | $34,000 | -17.1% | 1,727 | -14.0% | 0.01% | -36.4% |
| Q3 2017 | $41,000 | +78.3% | 2,008 | +25.0% | 0.02% | +69.2% |
| Q2 2017 | $23,000 | +64.3% | 1,607 | +71.1% | 0.01% | +62.5% |
| Q1 2017 | $14,000 | – | 939 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |